Adverum Biotechnologies ADVM
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2024Q2 | 6.86 | 113.02 | -0.81 | -20,882 | -18 | |
| 2024Q1 | 14.14 | 108.28 | -1.50 | -26,839 | -25 | |
| 2023Q4 | 7.53 | 105.28 | -2.30 | -26,158 | -24 | |
| 2023Q3 | 15.00 | 105.05 | -3.28 | -34,529 | -33 | |
| 2023Q2 | 15.90 | 105.00 | -3.12 | -33,065 | -32 | |
| 2023Q1 | 7.17 | 104.13 | -2.90 | -30,239 | -29 | |
| 2022Q4 | 5.80 | 103.74 | -3.30 | -33,940 | -33 | |
| 2022Q3 | 9.50 | 102.30 | -4.00 | -41,037 | -40 | |
| 2022Q2 | 12.00 | 100.65 | -4.50 | -44,025 | -44 | |
| 2022Q1 | 13.10 | 100.64 | -3.80 | -38,133 | -38 | |
| 2021Q4 | 17.60 | 100.03 | -3.50 | -34,419 | -34 | |
| 2021Q3 | 21.70 | 100.42 | -3.90 | -38,522 | -38 | |
| 2021Q2 | 35.00 | 100.46 | -4.50 | -44,538 | -44 | |
| 2021Q1 | 98.60 | 100.73 | -2.90 | -28,643 | -28 | |
| 2020Q4 | 108.40 | 99.62 | -3.90 | -36,380 | -38 | |
| 2020Q3 | 103.00 | 100.85 | -3.10 | -28,004 | -28 | |
| 2020Q2 | 208.80 | 101.97 | -3.70 | -29,775 | -29 | |
| 2020Q1 | 97.70 | 103.86 | -3.10 | -23,791 | -23 | |
| 2019Q4 | 115.20 | 103.85 | -3.00 | -19,653 | -19 | |
| 2019Q3 | 54.50 | 105.99 | -2.50 | -17,083 | -16 |